Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of the Advanced Practitioner in Oncology|July 18, 2014
Predictors of practice patterns for lymphedema care among oncology advanced practice nursesJoanne C Ryan, Charles M Cleland, Mei R Fu
Cancer Medicine|January 18, 2024
Disparities in care of older adults of color with cancer: A narrative reviewEfrat Dotan, Shannon M Lynch, Joanne C Ryan, et al.
Journal of the Advanced Practitioner in Oncology|January 18, 2021
Therapy Management Using Modified 2-Weeks-On/1-Week-Off Dosing Schedule in Patients With Metastatic Renal Cell Carcinoma Receiving Sunitinib: A Hypothetical, Illustrative Case ScenarioKimberly D Allman, Joanne C Ryan, Andrew Clair, et al.
Journal of the Advanced Practitioner in Oncology|June 27, 2022
Practical Strategies for Advanced Practitioners Streamlining the Integration of Oncology Biosimilar Therapies Into PracticeKelley D Mayden, John M Kelton, Joanne C Ryan, et al.
Future Oncology (London, England)|January 11, 2020
Understanding the adverse event experience in the S-TRAC adjuvant trial of sunitinib for high-risk renal cell carcinomaSarah Yenser Wood, Joanne C Ryan, Andrew G Clair, et al.
Oncology and Therapy|April 23, 2025
Survey of Health Care Providers on Social Determinants of Health and Treatment Decision-Making for Patients With HR+/HER2- Metastatic Breast CancerMonique Gary, Editha Krueger, Molly Kisiel, et al.
Journal of the Advanced Practitioner in Oncology|October 6, 2022
Timely Genetic Testing and Therapy Management in Patients With gBRCA-Mutated Metastatic Breast Cancer Receiving TalazoparibAshley Martinez, Tiffany Jones, Joanne C Ryan, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 20, 2020
Glasdegib plus low-dose cytarabine for acute myeloid leukemia: Practical considerations from advanced practitioners and pharmacistsValerie Relias, Ali McBride, Matthew J Newman, et al.
The Oncologist|March 23, 2023
Characteristics, Treatment, and Outcomes of Real-World Talazoparib-Treated Patients With Germline BRCA-Mutated Advanced HER2-Negative Breast CancerKristin M Zimmerman Savill, Jasmina Ivanova, Parisa Asgarisabet, et al.
Pageof 2